An interesting comment from Roche last week:
"While there has been some progress in solving the scientific and technical hurdles with RNAi, the hurdles remain, in particular cell specific delivery." Roche spokesman Darien E. Wilson told BioWorld Today.
- Forums
- ASX - By Stock
- PYC
- roche deal.
PYC
pyc therapeutics limited
Add to My Watchlist
1.89%
!
$1.30

roche deal., page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M |
Open | High | Low | Value | Volume |
$1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 1.250 |
2 | 22000 | 1.220 |
2 | 2166 | 1.200 |
1 | 8474 | 1.180 |
1 | 6000 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 10000 | 1 |
1.330 | 3633 | 1 |
1.340 | 9300 | 1 |
1.420 | 26097 | 2 |
1.425 | 25000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online